Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “LTD.”

1,301 pharma patents match "LTD." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,301
Index total 30,257
Page 26 / 55

Quick answer

This filtered view shows 1,301 pharmaceutical patents matching "LTD." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,301 results for “LTD.” · 30,257 patents in full index Clear search

  1. US 9107832

    Risperidone microparticles formed by sublimation

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Aug 18, 2015 · Expires Aug 13, 2035

    granted
  2. US 9102698

    Process for the synthesis of IB-MECA

    CAN-FITE BIOPHARMA LTD. · Granted Aug 11, 2015 · Expires Aug 6, 2035

    granted
  3. US 9102620

    Deuterated N-ethyl-N-phenyl-1,2-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide, salts and uses thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Aug 11, 2015 · Expires Aug 6, 2035

    granted
  4. US 9090598

    Nilotinib salts and crystalline forms thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jul 28, 2015 · Expires Jul 23, 2035

    granted
  5. US 9072763

    Methods and compositions for treating inflammatory bowel disease

    RedHill Biopharma Ltd. · Granted Jul 7, 2015 · Expires Jul 2, 2035

    granted
  6. US 9073989

    Antibiotic comprising an antibody mimetic, its preparation methods and uses thereof

    PROTEIN DESIGN LAB, LTD. · Granted Jul 7, 2015 · Expires Jul 2, 2035

    granted
  7. US 9066907

    Methods for treating burns-related systemic inflammatory response syndrome

    Biofunctional Structure Research Institute, BFSR Co. Ltd. · Granted Jun 30, 2015 · Expires Jun 25, 2035

    granted
  8. US 9063153

    Cytokine biomarkers as predictive biomarkers of clinical response for glatiramer acetate

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jun 23, 2015 · Expires Jun 18, 2035

    granted
  9. US 9056046

    Standardized extract and its use in the manufacture of a medicament

    Botanic Century (Beijing) Co. Ltd. · Granted Jun 16, 2015 · Expires Jun 11, 2035

    granted
  10. US 9051379

    Sp1 polypeptides, modified Sp1 polypeptides and uses thereof

    Fulcrum SP Ltd. · Granted Jun 9, 2015 · Expires Jun 4, 2035

    granted
  11. US 9050263

    Pharmaceutical compositions for the treatment of Helicobacter pylori

    RedHill Biopharma Ltd. · Granted Jun 9, 2015 · Expires Jun 4, 2035

    granted
  12. US 9029318

    Peptides and compositions for prevention of cell adhesion and methods of using same

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted May 12, 2015 · Expires May 7, 2035

    granted
  13. US 9018170

    Reduced volume formulation of glatiramer acetate and methods of administration

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 28, 2015 · Expires Apr 23, 2035

    granted
  14. US 9011888

    Organic-inorganic composite particles, process for producing the same, dispersion containing the particles, and cosmetic containing the particles

    JGC Catalysts and Chemicals Ltd. · Granted Apr 21, 2015 · Expires Apr 16, 2035

    granted
  15. US 9012641

    Crystalline forms of Prasugrel salts

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 21, 2015 · Expires Apr 16, 2035

    granted
  16. US 9005638

    Cosmetics containing a multi-functional composite powder

    JGC Catalysts and Chemicals Ltd. · Granted Apr 14, 2015 · Expires Apr 9, 2035

    granted
  17. US 8993519

    Method of treatment for neutropenia using stable formulations of recombinant human albumin-human granulocyte colony stimulating factor

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 31, 2015 · Expires Mar 26, 2035

    granted
  18. US 8987228

    Pharmaceutical composition including an A3 adenosine receptor agonist 1-deooxy-1-[N6-(3-idobenzyl)-adenin-9-yl]-N-methyl-β-D-ribofuronamide(IB-MECA/CF-101) for treatment of psoriasis

    CAN-FITE BIOPHARMA LTD. · Granted Mar 24, 2015 · Expires Mar 19, 2035

    granted
  19. US 8980343

    Plant extract, compositions containing same, method of extraction and uses thereof

    Botanic Century (Beijing) Co. Ltd. · Granted Mar 17, 2015 · Expires Mar 12, 2035

    granted
  20. US 8980549

    MicroRNA patterns for the diagnosis, prognosis and treatment of melanoma

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Mar 17, 2015 · Expires Mar 12, 2035

    granted
  21. US 8975282

    Substituted pyrazolone compounds and methods of use

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Mar 10, 2015 · Expires Mar 5, 2035

    granted
  22. US 8975279

    Amine salts of laquinimod

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 10, 2015 · Expires Mar 5, 2035

    granted
  23. US 8969388

    Substituted pyrazolone compounds and methods of use

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Mar 3, 2015 · Expires Feb 26, 2035

    granted
  24. US 8969296

    TGFP-CAP peptide and its uses

    CAREGEN CO., LTD. · Granted Mar 3, 2015 · Expires Feb 26, 2035

    granted